NCCM
CLB icon

Nine Chapters Capital Management’s Core Laboratories CLB Stock Holding History

Nine Chapters Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,700
Closed -$422K – 1021
2015
Q2 		$422K Buy
+3,700
New +$449K 0.04% 635
2015
Q1 		– Sell
-15,500
Closed -$1.86M – 976
2014
Q4 		$1.86M Buy
+15,500
New +$2.04M 0.16% 173

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nine Chapters Capital Management's CLB Position: Q3 2015 in Review

Nine Chapters Capital Management sold out of Core Laboratories (CLB) in Q3 2015, closing a stake of 3,700 shares — an estimated $422K sold.

Nine Chapters Capital Management first reported a position in CLB in Q4 2014 and held it in 2 quarters. The position peaked at $1.86M in Q4 2014. 351 funds tracked by Wall St. Rank hold CLB as of Q3 2015.

  • Nine Chapters Capital Management reported no remaining Core Laboratories position as of Q3 2015 after selling out during the quarter.
  • Nine Chapters Capital Management sold 3,700 Core Laboratories shares in Q3 2015, an estimated $422K.
  • Nine Chapters Capital Management first reported a position in Core Laboratories in Q4 2014 and held it in 2 quarters.
  • Nine Chapters Capital Management's Core Laboratories position peaked at $1.86M in Q4 2014.
  • 351 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2015.

Based on Nine Chapters Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.